Hara Capital’s AbbVie ABBV Stock Holding History

Hara Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$663K	Hold	3,048	–	–	0.33%	71
2025 Q4	$696K	Hold	3,048	–	–	0.39%	64
2025 Q3	$706K	Hold	3,048	–	–	0.42%	55
2025 Q2	$566K	Sell	3,048 -100	-3%	-$18.6K	0.35%	65
2025 Q1	$660K	Sell	3,148 -3,218	-51%	-$626K	0.45%	52
2024 Q4	$1.13M	Buy	6,366 +3,183	+100%	+$585K	0.36%	69
2024 Q3	$629K	Sell	3,183 -113	-3%	-$21.1K	0.39%	52
2024 Q2	$565K	Hold	3,296	–	–	0.36%	63
2024 Q1	$600K	Sell	3,296 -155	-4%	-$26.7K	0.36%	61
2023 Q4	$535K	Buy	+3,451	New	+$503K	0.38%	57

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hara Capital's ABBV Position: Q1 2026 in Review

Hara Capital held its AbbVie (ABBV) position steady in Q1 2026 at 3,048 shares worth $663K. The position accounts for 0.33% of the portfolio, ranked #71.

Hara Capital first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.13M in Q4 2024. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Hara Capital held 3,048 shares of AbbVie worth $663K as of Q1 2026.
Hara Capital left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.33% of Hara Capital's portfolio in Q1 2026, its #71 holding.
Hara Capital first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Hara Capital's AbbVie position peaked at $1.13M in Q4 2024.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.